[1] [2] The decision to stop tirzepatide may arise from various circumstances: achievement of treatment goals, intolerable side effects, insurance coverage changes, cost considerations, pregnancy, or medical contraindications (including medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or serious hypersensitivity reactions, as noted in the boxed warning)
These participants not only maintained their weight but also lost an additional 1.8% of their body weight on average over 13 weeks [1]
Intolerable GI adverse effects
Tracking metrics beyond scale weightsuch as how your clothes fit, energy levels, and hunger patternsprevents obsessive weighing while keeping you accountable
Log in to view the benefits included in your plan.